Marketplace Logo Donate

Daily business news and economic stories from Marketplace

Here’s why there’s a shortage of EpiPens

Subscribe to our Newsletters

The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen products. The FDA got data from EpiPen maker Mylan that convinced them some of the devices already on the market will work a bit longer.

Click the audio player above to hear the full story. 

What's Next

Latest Episodes From Our Shows

Listen
4:50 PM PDT
17:36
Listen
4:27 PM PDT
25:43
Listen
1:47 PM PDT
1:50
Listen
7:58 AM PDT
7:32
Listen
Oct 3, 2022
4:41
Listen
Sep 29, 2022
2:55
Listen
Aug 9, 2022
24:46
Exit mobile version